The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis

Olivier Imbert,Henri Deckx,Katy Bernard,Ellen van der Aar,Maria Pueyo, Nadeem Saeed,Thomas Fuerst,Wolfgang Wirth,Philip G. Conaghan,Felix Eckstein

Osteoarthritis and Cartilage Open（2021）

Cited 7|Views11

No score

Abstract

Using strict inclusion criteria and leading imaging techniques with stringent quality controls, the ROCCELLA trial will evaluate the efficacy of S201086/GLPG1972 in slowing cartilage loss in participants with knee OA. The selected eligibility criteria should enrich for participants with OA who experience sufficient cartilage loss to allow detection of a substantial treatment effect.

Translated text

Key words

Knee osteoarthritis,Cartilage,Clinical trial,Disease modification,Quantitative magnetic resonance imaging,ADAMTS-5 inhibitor

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined